CatalystWireBeta

UK small-cap RNS · 26 Aug 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 18:36
    Completion of Directors’ Subscription Fundraise
    The placing and direct subscription rise to £4.11m at 5p, an 81% discount to the last close, with 10p warrants attached. The total fundraise is unchanged, but new shares dilute existing holders.
    Dilutive fundraise £0.8m · 9% of mcap +0.0% on the day
    Moved: Going concern and cash shortfall: Oversubscribed £5.1m raise awaiting completion → Directors' subscription completed; admission expected 28 August · GEM share subscription facility: Awaiting fundraise completion → Awaiting completion; extra warrants on directors' shares
  2. 16:55
    Final Results Results
    Audited FY25 revenue is restated down to €5.7m after Chinese irregularities. FY26 revenue is now circa €1.8m against the earlier €7.8m guidance. Both reflect the cut already made after the delayed €6m orders.
    Dilutive fundraise £5.1m · 60% of mcapbelow expectationsoutlook mixed3 profit warnings in 3 months – usually less than 1 +0.0% on the day
    Moved: Accounting irregularities and suspension: Accounts due by 26 August; suspension to lift 27 August → Audited accounts published; readmission pending · Going concern and cash shortfall: Fundraise terms announced; unconditional steps pending → Oversubscribed £5.1m raise awaiting completion · GEM share subscription facility: GEM warrants to be repriced after the fundraise → Awaiting fundraise completion
  3. 16:37
    Holding(s) in Company Holding
  4. 16:00
    Director/PDMR Shareholding Director dealing
  5. 14:10
    Director/PDMR Shareholding Director dealing
  6. 11:12
    Holding(s) in Company Holding
  7. 07:00
    4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
    a specialist in enzymatically-produced, cell-free DNA for new genetic medicines, announces that it has signed a non-exclusive Strategic Collaboration and Marketing Agreement with Genezen, a best-in-class viral vector contract development and manufacturing …
    Dilutive fundraise +1.1% on the day
    Moved: Leadership transition and commercial push: First new contract under new CEO → New CDMO sales channel added under new CEO
  8. 07:00
    Sea Lion Reserves Evaluation
    Sea Lion Independent Recoverable Reserves and Resources Evaluation
    Moved: OSX-1 FPSO and CDA acceleration: Navitas buying OSX-1; Rockhopper funding via placing → OSX-1 acquisition; CDA now in NSAI evaluation
  9. 07:00
    Kabwe Drilling (“KBDD11”)
    The New Ore body identified at Kabwe returns a max grade of 70% Zn.
    Project milestones +3.2% on the day
    Moved: Kabwe drilling programme: Phase 1 extended to 2,500m; 2 of 3 new-orebody holes reported → Phase 1 drilling complete; assays and reporting pending
  10. 07:00
    Preferred Purchaser Selected for LWP Sale
    Selects a preferred purchaser at US$35.0m for the greenfield LWP, a substantial premium to cost, to redeploy into lower-risk Zambian copper growth. Not yet signed; due diligence and 3-year staged payments remain.
    Moved: Large Waste Project: Two binding offers received; sale to be agreed → Preferred purchaser selected; due diligence under way
  11. 07:00
    FY26 Trading Update Trading update
    Applied Nutrition plc, a leading sports nutrition, health and wellness brand, today announces an update on trading for the financial year ended 31 July 2026 ("FY26") and outlook for the financial year ending 31 July 2027 ("FY27").
    Upgrade / downgrade cycle ahead of expectations −1.6% on the day
  12. 07:00
    Q2 Activities Update
    Routine quarterly update required by the bond terms; dewatering and civil works progress, but cash outside escrow is only £12.0m at 30 June and the project finance package is still incomplete.
    Project milestones outlook positivefirst since Oct 2023 +0.5% on the day
    Moved: South Crofty development and financing: Bridge facilities signed; equity raise and FID pending → Bond issued; equity raise and FID pending
  13. 07:00
    Kakuzi profits announcement
    Kakuzi, a 50.7%-owned subsidiary, flags net earnings at least 25% lower for 2026, and Camellia says Gulf events hurt several operating companies' trading profits, offset only partly by improvement elsewhere under the VEP.
    Upgrade / downgrade cycle below expectationsoutlook mixed, loweredfirst in 2 years −4.2% on the day
    Moved: Return Camellia to sustainable operating profitability: on_track → delayed – Gulf-related headwinds in several operating companies and Kakuzi's lower profit outlook, with the full-year outcome hard to predict, put sustainable operating profitability at risk.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note